Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Gross Profit (2018 - 2025)

Historic Gross Profit for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $84.6 million.

  • TransMedics' Gross Profit rose 3900.07% to $84.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.4 million, marking a year-over-year increase of 4345.23%. This contributed to the annual value of $262.1 million for FY2024, which is 7007.98% up from last year.
  • Per TransMedics' latest filing, its Gross Profit stood at $84.6 million for Q3 2025, which was up 3900.07% from $96.6 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Gross Profit registered a high of $96.6 million during Q2 2025, and its lowest value of $3.8 million during Q3 2021.
  • In the last 5 years, TransMedics' Gross Profit had a median value of $36.7 million in 2023 and averaged $40.6 million.
  • As far as peak fluctuations go, TransMedics' Gross Profit plummeted by 2510.92% in 2021, and later soared by 38012.19% in 2022.
  • TransMedics' Gross Profit (Quarter) stood at $7.0 million in 2021, then skyrocketed by 196.35% to $20.7 million in 2022, then soared by 131.48% to $47.9 million in 2023, then surged by 50.27% to $72.0 million in 2024, then increased by 17.44% to $84.6 million in 2025.
  • Its Gross Profit was $84.6 million in Q3 2025, compared to $96.6 million in Q2 2025 and $88.2 million in Q1 2025.